#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepato-lenticular degeneration Neuronal ceroid lipofuscinosis Hepatocellular carcinoma Ovarian cancer stage III Synovial sarcoma metastatic Stargardt's disease Neonatal alloimmune thrombocytopenia Pericarditis Deafness neurosensory Small for dates baby Myotonic dystrophy Amyloidosis Anti-HLA antibody test positive Nephropathy Glomerulonephritis chronic More trials…

    Learn about Rare Diseases

    Paraneoplastic neurological syndrome – Treatment Marginal zone lymphoma refractory – Treatment Gaucher’s disease type I Primary immunodeficiency syndrome – Life with Disease Burkitt’s lymphoma – Life with Disease SAPHO syndrome – Trials in Disease Skin angiosarcoma – Life with Disease Von Willebrand’s disease – Trials in Disease Paraneoplastic neurological syndrome Mucopolysaccharidosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cetirizine Dihydrochloride Pantothenate Sodium Exidavnemab Selpercatinib Capivasertib Bms-986408 Vonafexor Afatinib Mr0005 ZELENECTIDE PEVEDOTIN Nivolumab Immunostimulants Gallium (68Ga) Chloride Hydrocortisone Acetate IMB 101 Platelet Concentrate Peposertib Ipn01194 Sildenafil Citrate Ucp2 More therapies…

    Learn about Your Condition

    Cerebral palsy Dermatitis atopic Optic atrophy Systemic infection Toxicity to various agents Cleft lip and palate Cardiac disorder Rectal cancer recurrent Pyelonephritis acute Type IIa hyperlipidaemia Type 2 diabetes mellitus Diabetic retinal oedema Ectopic pregnancy Antisynthetase syndrome Peritonitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ovarian cancer metastatic

  • Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer metastatic
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated Drugs:
    • Mirvetuximab Soravtansine
    • LY4170156
    • Topotecan
    Austria Belgium Czechia Denmark France Germany +9

  • Study on the Impact of Exercise and Atorvastatin on Advanced Breast, Ovarian, Prostate, and Kidney Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer metastatic
    • Renal cancer
    • Prostate cancer metastatic
    Investigated Drugs:
    • Atorvastatin
    Finland

  • Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Biliary cancer metastatic
    • Breast cancer recurrent
    • Breast cancer stage IV
    Investigated Drugs:
    • Ds-3939A
    Belgium France Spain

  • Study on Mirvetuximab Soravtansine and Carboplatin for Patients with Recurrent Ovarian Cancer Eligible for Platinum-Based Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer metastatic
    • Ovarian cancer metastatic
    • Fallopian tube cancer
    Investigated Drugs:
    • Mirvetuximab Soravtansine
    • Niraparib Tosilate Monohydrate
    • Doxorubicin Hydrochloride, Liposomal
    Germany

  • Study on the Safety and Effects of ICT01, Aldesleukin, and Pembrolizumab for Patients with Advanced Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer metastatic
    • Pancreatic carcinoma metastatic
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Ict01
    • Aldesleukin
    • Pembrolizumab
    France Germany

  • Study on the Safety and Effects of LY2880070 and Gemcitabine in Patients with Advanced or Metastatic Cancer, Focusing on Ovarian Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer metastatic
    • Ovarian cancer
    • Neoplasm malignant
    Investigated Drugs:
    • Gemcitabine
    • Gemcitabine Hydrochloride
    Croatia Poland

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!